Valuation: Mirion Technologies, Inc.

Market Cap 3.67B 62.84B 3.17B 2.97B 2.71B 5.11B 350B 5.19B 34.79B 13.65B 175B 13.77B 13.47B 583B P/E 2026 *
78.6x
P/E 2027 * 46.9x
Enterprise Value 4.36B 74.8B 3.78B 3.53B 3.23B 6.08B 416B 6.18B 41.4B 16.25B 208B 16.38B 16.03B 693B EV / Sales 2026 *
3.83x
EV / Sales 2027 * 3.43x
Free-Float
92.2%
Yield 2026 *
-
Yield 2027 * -
1 day-14.47%
3 months-14.47%
6 months-14.47%
Current year-14.47%
Current year 321.32
Extreme 321.32
321.32
1 year 321.32
Extreme 321.32
321.32
3 years 303.6
Extreme 303.6
375.7
5 years 303.6
Extreme 303.6
375.7
10 years 303.6
Extreme 303.6
375.7
Manager TitleAgeSince
Chief Executive Officer 65 2021-10-19
President 50 -
Director of Finance/CFO 42 2019-12-31
Director TitleAgeSince
Chairman 65 2025-01-31
Chairman 63 2021-10-19
Director/Board Member 65 2021-10-19
Change 5-day change 1-year change 3-year change Capi.($)
-14.47%-.--% - - 3.67B
-1.63%+4.20%+103.33%+112.93% 57.32B
-4.14%-5.69%+194.20%+202.77% 19.77B
+3.26%+19.63%+341.96%+356.72% 18.91B
-3.78%-4.57%+57.32%+30.13% 10.83B
+5.25%+41.11%+304.57%+153.67% 9.77B
+1.14%+11.44%+7.81%+79.09% 9B
-1.61%-5.44%+55.65%+188.02% 7.79B
+2.88%+6.51%+54.20% - 7.68B
-1.53%-3.59%-8.00%+13.38% 7.17B
Average -1.46%+84.79%+123.45%+142.09% 16.47B
Weighted average by Cap. -0.97%+180.58%+139.56%+151.74%

Financials

2026 *2027 *
Net sales 1.14B 19.51B 985M 921M 842M 1.59B 109B 1.61B 10.8B 4.24B 54.31B 4.27B 4.18B 181B 1.22B 20.98B 1.06B 990M 905M 1.71B 117B 1.73B 11.61B 4.56B 58.39B 4.59B 4.49B 194B
Net income 51.14M 877M 44.27M 41.38M 37.82M 71.27M 4.88B 72.38M 485M 190M 2.44B 192M 188M 8.13B 87.16M 1.49B 75.46M 70.53M 64.46M 121M 8.31B 123M 827M 325M 4.16B 327M 320M 13.85B
Net Debt 697M 11.95B 604M 564M 516M 972M 66.51B 987M 6.62B 2.6B 33.27B 2.62B 2.56B 111B 529M 9.07B 458M 428M 391M 737M 50.44B 749M 5.02B 1.97B 25.23B 1.99B 1.94B 84.05B
Logo Mirion Technologies, Inc.
Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets. The Company's segments include Medical, and Nuclear & Safety. The Medical segment includes products and services for radiation therapy, nuclear medicine and personal dosimetry. This segment’s principal product offering is in Radiation Therapy Quality Assurance, which includes solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy. The Nuclear & Safety segment includes products and services focused on addressing critical radiation safety, measurement and analysis applications across nuclear energy, laboratories and research and other industrial markets such as defense. For nuclear power plants (NPPs), it sells products and services for use at any stage of their life (construction, operation, decommissioning and dismantling).
Employees
3,281
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
15.07USD
Average target price
24.60USD
Spread / Average Target
+63.24%

Quarterly revenue - Rate of surprise